ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,301,373 | -9.0% | 210,171 | +10.1% | 0.00% | 0.0% |
| Q2 2023 | $2,527,688 | +1.5% | 190,913 | +4.3% | 0.00% | 0.0% |
| Q1 2023 | $2,490,167 | -30.1% | 182,966 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $3,564,010 | +5.0% | 182,489 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $3,394,000 | +9.2% | 178,167 | +18.1% | 0.00% | 0.0% |
| Q2 2022 | $3,108,000 | -33.7% | 150,879 | +3.5% | 0.00% | 0.0% |
| Q1 2022 | $4,690,000 | -29.4% | 145,749 | +2.2% | 0.00% | -50.0% |
| Q4 2021 | $6,639,000 | +75.0% | 142,575 | +1.5% | 0.00% | +100.0% |
| Q3 2021 | $3,794,000 | +52.3% | 140,518 | +44.7% | 0.00% | 0.0% |
| Q2 2021 | $2,491,000 | -22.3% | 97,086 | +3.6% | 0.00% | 0.0% |
| Q1 2021 | $3,204,000 | +26.7% | 93,712 | +25.4% | 0.00% | 0.0% |
| Q4 2020 | $2,529,000 | +48.2% | 74,751 | +8.1% | 0.00% | 0.0% |
| Q3 2020 | $1,706,000 | – | 69,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |